We are live on
!
Find out more
Structure Therapeutics
GPCR
GPCR
196 hedge funds and large institutions have $3.22B invested in Structure Therapeutics in 2026 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 73 increasing their positions, 58 reducing their positions, and 39 closing their positions.
New
Increased
Maintained
Reduced
Closed
45% more call options, than puts
Call options by funds: $27.4M | Put options by funds: $18.9M
26% more repeat investments, than reductions
Existing positions increased: 73 | Existing positions reduced: 58
0% more first-time investments, than exits
New positions opened: 39 | Existing positions closed: 39
1% less funds holding
Funds holding: 197 → 196 (-1)
14.16% less ownership
Funds ownership: 108.4% → 94.24% (-14%)
30% less capital invested
Capital invested by funds: $4.58B → $3.22B (-$1.36B)
63% less funds holding in top 10
Funds holding in top 10: 16 → 6 (-10)
Holders
196
Holders Change
-1
Holders Change %
-0.51%
% of All Funds
2.41%
Holding in Top 10
6
Holding in Top 10 Change
-10
Holding in Top 10 Change %
-62.5%
% of All Funds
0.07%
New
39
Increased
73
Reduced
58
Closed
39
Calls
$27.4M
Puts
$18.9M
Net Calls
+$8.44M
Net Calls Change
-$35.9M
Top Buyers
| 1 |
American Century Companies
Kansas City,
Missouri
|
+$63.7M |
| 2 |
PBA
Paradigm Biocapital Advisors
New York
|
+$37.3M |
| 3 |
Principal Financial Group
Des Moines,
Iowa
|
+$32.1M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$22.6M |
| 5 |
O
OrbiMed
New York
|
+$21.5M |
